Purpose: To evaluate and compare visual performance of two enhanced monofocal intraocular lenses (IOLs), XY1-EM (Vivinex Impress, Hoya) and DIB00V (TECNIS Eyhance, Johnson & Johnson) with that of a conventional monofocal IOL, XY-1 (Vivinex, Hoya).
Setting: Kamiamakusa General Hospital, Kumamoto, Japan.
Methods: A retrospective analysis was conducted on 130 eyes from 75 patients, including 46 eyes (27 patients) implanted with XY1-EM, 47 eyes (26 patients) with DIB00V, and 37 eyes (22 patients) with XY-1.
Results: Corrected-distance visual acuity was comparable across all three groups. Both enhanced monofocal IOLs (XY1-EM and DIB00V) demonstrated significantly superior distance-corrected visual acuity at 70 cm and 50 cm compared to the conventional monofocal IOL (XY1). The rates of spectacle independence were also significantly higher in the enhanced monofocal IOL groups. In a direct comparison between the two enhanced monofocal IOLs, XY1-EM exhibited a significantly better defocus curve at -1.5D than DIB00V. Patients reported higher subjective satisfaction for "reading a newspaper" and "speed of adaptation to daily vision" in the XY-1 group compared to the DIB00V group.
Conclusions: The new enhanced monofocal IOL, Vivinex Impress XY1-EM, demonstrated significantly improved intermediate visual acuity compared to the conventional monofocal IOL. It also showed slightly superior intermediate visual acuity and higher subjective satisfaction compared to the other enhanced monofocal IOL evaluated in this study.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/j.jcrs.0000000000001641 | DOI Listing |
Front Med (Lausanne)
February 2025
Sussex Eye Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom.
Purpose: Mini-monovision is a vision correction technique that allows for a broader spectrum of spectacle independence while minimizing anisometropia. This systemic review aims to evaluate the clinical outcomes of pseudophakic mini-monovision with three types of intraocular lenses (IOLs): monofocal, enhanced monofocal, and extended depth of focus (EDOF).
Methods: A comprehensive literature search was conducted using PubMed and MEDLINE to identify studies reporting mini-monovision outcomes within the three categories of IOLs up to July 2024.
Clin Ther
March 2025
Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Bocconi University, Milan, Italy; Department of Social and Political Sciences, Bocconi University, Milan, Italy.
Aim: Cataract is a prevalent health condition, primarily caused by aging, affecting approximately 95 million individuals worldwide. The only effective treatment currently involves surgically removing and replacing the crystalline lens with an artificial intraocular lens (IOL). Various IOLs are available, each with distinct characteristics, costs, and outcomes.
View Article and Find Full Text PDFIndian J Ophthalmol
March 2025
Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Purpose: To evaluate the optical performance of an enhanced monofocal intraocular lens (IOL) in the presence of cataract and a low degree of corneal astigmatism.
Methods: A prospective, comparative, nonrandomized study was conducted to compare the results of an enhanced monofocal IOL with a standard monofocal IOL in cases of cataract with corneal astigmatism ≥0.75 D and <1.
J Cataract Refract Surg
February 2025
Department of Ophthalmology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Purpose: To evaluate and compare visual performance of two enhanced monofocal intraocular lenses (IOLs), XY1-EM (Vivinex Impress, Hoya) and DIB00V (TECNIS Eyhance, Johnson & Johnson) with that of a conventional monofocal IOL, XY-1 (Vivinex, Hoya).
Setting: Kamiamakusa General Hospital, Kumamoto, Japan.
Methods: A retrospective analysis was conducted on 130 eyes from 75 patients, including 46 eyes (27 patients) implanted with XY1-EM, 47 eyes (26 patients) with DIB00V, and 37 eyes (22 patients) with XY-1.
Eye (Lond)
February 2025
Konyagoz Eye Hospital, Konya, Türkiye.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!